Echocardiographic Parameters During and Beyond Onset of Kawasaki Disease Correlate with Onset Serum N-Terminal pro-Brain Natriuretic Peptide (NT-proBNP)

被引:0
作者
Laurent Desjardins
Audrey Dionne
Léamarie Meloche-Dumas
Anne Fournier
Nagib Dahdah
机构
[1] Université de Montréal,Division of Pediatric Cardiology, CHU Mère
[2] Dalhousie University,Enfant Ste
[3] Harvard Medical School,Justine
来源
Pediatric Cardiology | 2020年 / 41卷
关键词
Kawasaki disease; Vasculitis; NTpro-BNP; Biomarker; Systolic and diastolic function;
D O I
暂无
中图分类号
学科分类号
摘要
The N-terminal proBNP (NT-proBNP), produced by cardiomyocytes, has several reported utilities and associations in acute Kawasaki disease (KD). The objective of this study is to examine the relationship between serum values of NT-proBNP at time of KD diagnosis with cardiac systolic, diastolic function and electrocardiographic changes, at onset of the disease and during the first year of follow-up. KD was diagnosed in 127 children between March 2007 and July 2014, mean diagnostic age 3.5 ± 2.9 years. Coronary artery maximum z score was 2.6 ± 2.8 (range − 0.6 to + 18.9), with giant aneurysm in 5/122 (4.1%). Age-adjusted NT-proBNP was 2.6 ± 1.6 z score, 78/122 (63.9%) > 2.0. There was a crescendo correlation between onset NT-proBNP z score and C-Reactive protein (CRP) serum levels (slope + 0.49, p < 0.001). There was a crescendo correlation between NT-proBNP z score and indexed left ventricular (LV) mass (slope + 1.86, p = 0.02), LV diastolic function parameter E/e′ ratio (slope + 0.31, p = 0.04) and a decrescendo correlation with age-adjusted LV shortening fraction (SF) (− 0.63, p = 0.02). Lower SF z score, higher left ventricular mass index and E/e′ ratio were associated with higher NT-proBNP z score, but without correlation with CRP levels. Within 2–3 months from the onset of the disease, there was a resolution of the systolic dysfunction. Electrocardiographic parameter changes were associated with decreased LV shortening fraction but not with NT-proBNP. KD patients with elevated NT-proBNP at onset have sub-clinical myocardial involvement and might benefit from follow-up and continued evaluation, even in the absence of coronary artery involvement.
引用
收藏
页码:947 / 954
页数:7
相关论文
共 288 条
[1]  
Burns JC(2004)Kawasaki syndrome Lancet 364 533-544
[2]  
Glode MP(1991)Nationwide survey of Kawasaki disease and acute rheumatic fever J Pediatr 119 279-282
[3]  
Taubert KA(2017)Diagnosis, treatment, and long-term management of Kawasaki Disease: a scientific statement for health professionals from the American Heart Association Circulation 135 e927-e999
[4]  
Rowley AH(2015)Usefulness of natriuretic peptide for the diagnosis of Kawasaki disease: a systematic review and meta-analysis BMJ Open 5 e006703-2101
[5]  
Shulman ST(2013)N-terminal pro-brain natriuretic Peptide as a useful diagnostic marker of acute Kawasaki disease in children Circ J 77 2097-633
[6]  
McCrindle BW(2012)Value of amino-terminal pro B-natriuretic peptide in diagnosing Kawasaki disease Pediatr Int 54 627-1318
[7]  
Rowley AH(2015)N-terminal pro-brain natriuretic peptide in acute Kawasaki disease correlates with coronary artery involvement Cardiol Young 25 1311-257
[8]  
Newburger JW(1996)Sequelae of Kawasaki disease in adolescents and young adults J Am Coll Cardiol 28 253-103
[9]  
Burns JC(2013)QT dispersion and T wave peak-to-end interval dispersion in children with Kawasaki disease Int Cardiovasc Res J 7 99-1018
[10]  
Bolger AF(2008)Accurate electrocardiographic assessment of the QT interval: teach the tangent Heart Rhythm 5 1015-672